Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 17, 2026, the Board of Directors (the "Board") of Greenland Mines Ltd. (the "Company") appointed Jason D. Sawyer to serve as a member of the Board, effective immediately, to fill a vacancy on the Board. Mr. Sawyer will serve until the Company's next annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier resignation or removal0

Mr. Sawyer has not been appointed to serve on any committees of the Board at this time.

Mr. Sawyer does not have any family relationship with any of the executive officers or directors of the Company and is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Mr. Sawyer has not entered into any agreement with the Company in connection with his appointment as a director.

Biography - Jason D. Sawyer, age 54, is a 33-year veteran of the alternative investment industry and the General Manager of Access Alternative Group S.A., a Nassau, Bahamas-based venture investment, and advisory firm. Over his career, Mr. Sawyer, and the firms in which he was a principal have raised more than $5 billion in alternative assets and deployed more than US$300 million in early and growth-stage investments across software, fintech, blockchain, biotech, clean tech, natural resources, health and fitness, energy, and consumer products. His prior roles include Principal at Crane Capital Associates and Head of its Absolute Return Strategies Group and Founding Partner of Candlebrook Capital, which was an early sponsor of best-in-class ABL funds such as Brevet Capital and Third Eye Capital, as well as numerous other brand-name private equity and hedge funds. He has also co-founded and financed ventures such as Pacific West Stone, California Fitness, Sanna Health Corp., and Caary Capital. Mr. Sawyer currently serves as CEO and a Director on the Board of GridAI Technologies Corp. (Nasdaq: GRDX), and in an advisory role as Head of Finance and M&A at Quantum BioPharma (Nasdaq: QNTM). He is a Director on the Board of The FUTR Corp. (TSX.V: FTRC), serves as a Director on the Board of Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), where he chairs the Compensation Committee and is a member of the Audit Committee, and is a Director on the Board of Perpetuals.com (Nasdaq: PDC), where he acts as Statutory Auditor.